Analysis of the Relationship between PPAR-γ 2 Gene Variants and Severe Insulin Resistance in Obese Patients with Impaired Glucose Tolerance

Abstract

Mutations in the peroxisome proliferator-activated receptor-γ 2 (PPAR-γ 2) gene may cause obesity and insulin resistance. Therefore we investigated whether known variants in the PPAR-γ 2 gene are associated with obesity and extreme insulin resistance in obese patients with impaired glucose tolerance (IGT). The Pro115 Gln, Pro12Ala, Pro467Leu, Val290Met and a silent polymorphism C478 T were examined in 48 subjects with IGT and insulin resistance (IR), characterized by euglycemic hyperinsulinemic clamps, and in 52 healthy insulin sensitive (IS) controls.

We found one proband in the IR group with the Pro115 Gln variant. This subject showed a lower whole body glucose uptake (18 µmol/kg per min) compared to the entire IR group (29 µmol/kg per min). The body weight of the proband (BMI 28.5 kg/m²) was within the average of the IR group (30.3 ± 0.8 kg/m²). The Pro12Ala variant was not associated with differences in BMI, in the degree of insulin resistance between the IR and IS group. The Pro467Leu, Val290Met mutations and the silent polymorphism CAC478CAT were not detected in any group. In conclusion, the Pro115 Gln variant, but not the Pro12Ala mutation in the PPAR-γ 2 gene, could be a rare cause of severe insulin resistance.

Key words

PPAR-γ 2 - Pro115 Gln variant - Insulin resistance - Impaired glucose tolerance

References

• 1 Altshuler D, Hirschhorn J N, Klannemark M, Lindgren C M, Vohl M C, Nemesh J, Lane C R, Schaffner S F, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson T J, Daly M, Groop L, Lander E S. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.  Nat Genet. 2000;  26 76-80
• 2 Barroso I, Gurnell M, Crowley V E, Agostini M, Schwabe J W, Soos M A, Maslen G L, Williams T D, Lewis H, Schafer A J, Chatterjee V K, O'Rahilly S. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension.  Nature. 1999;  402 880-883
• 3 Beamer B A, Yen C J, Andersen R E, Muller D, Elahi D, Cheskin L J, Andres R, Roth J, Shuldiner A R. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations.  Diabetes. 1998;  47 1806-1808
• 4 Blüher M, Kratzsch J, Paschke R. Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone and IGF-1 are not elevated in insulin resistant obese individuals with impaired glucose tolerance.  Diabetes Care. 2001;  24 328-334
• 5 Deeb S S, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.  Nat Genet. 1998;  20 284-287
• 6 DeFronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance.  Am J Physiol. 1979;  237 E214-E223
• 7 Ek J, Andersen G, Urhammer S A, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians.  Diabetologia. 2001;  44 1170-1176
• 8 Ek J, Urhammer S A, Sorensen T I, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men.  Diabetologia. 1999;  42 892-895
• 9 The Expert Committee on the Diagnosis and Classification of Diabetes mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus (Committee Report).  Diabetes Care. 1998;  21 (Suppl 1) S5-S19
• 10 Hamann A, Münzberg H, Buttron P, Busing B, Hinney A, Mayer H, Siegfried W, Hebebrand J, Greten H. Missense variants in the human peroxisome proliferator-activated receptor-γ2 gene in lean and obese subjects.  Eur J Endocrinol. 1999;  141 90-92
• 11 Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring H U. The PPAR-γ2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.  Diabetologia. 1999;  42 758-762
• 12 Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Rettig A, Renn W, Haring H U. The silent PPARgamma exon 6 CAC(His) -> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.  Exp Clin Endocrinol Diabetes. 2000;  108 341-346
• 13 Kraegen E W, Cooney G J, Ye J, Thompson A L. Triglycerides, fatty acids and insulin resistance - hyperinsulinemia.  Exp Clin Endocrinol Diabetes. 2001;  109 S516-S526
• 14 Miles P D, Barak Y, He W, Evans R M, Olefsky J M. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.  J Clin Invest. 2000;  105 287-292
• 15 Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer B A, Shuldiner A R, Akanuma Y, Yazaki Y, Kadowaki T. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor -γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.  Biochem Biophys Res Commun. 1998;  251 195-198
• 16 Nicklas B J, van Rossum E F, Berman D M, Ryan A S, Dennis K E, Shuldiner A R. Genetic variation in the peroxisome proliferator-activated receptor gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight gain.  Diabetes. 2001;  50 2172-2176
• 17 Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn C R. Human obesity associated with a mutation in PPARγ2, a regulator of adipocyte differentiation.  N Engl J Med. 1998;  339 953-959
• 18 Schwartz M W, Kahn S E. Insulin resistance and obesity.  Nature. 1999;  402 860-861
• 19 Spiegelman B M. PPARγ: adipogenic regulator and thiazolidinedione receptor.  Diabetes. 1998;  47 507-514
• 20 Trültzsch B, Krohn K, Wonerow P, Paschke R. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing.  Biotechniques. 1999;  27 266-268
• 21 Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb S S, Auwerx J, Uusitupa M, Laakso M. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women.  J Clin Endocrinol Metab. 1999;  84 3708-3712
• 22 Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited.  J Clin Invest. 1997;  100 86-96
• 23 Witchel S F, White C, Siegel M E, Aston C E. Inconsistent effects of the proline (12) → alanine variant of the peroxisome proliferator-activated receptor gamma2 gene on body mass index in children and adolescent girls.  Fertil Steril. 2001;  76 741-747
• 24 Yen C J, Beamer B A, Negri C, Silver K, Brown K A, Yarnall D P, Burns D K, Roth J, Shuldiner A R. Molecular scanning of the human peroxisome proliferator-activated receptor-γ (PPAR-γ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation.  Biochem Biophys Res Commun. 1997;  240 270-274